SI9400079B
(en)
*
|
1994-02-15 |
2003-02-28 |
Dr. Weidner Eckhard, Dipl. Ing. |
Method and device for extraction and fractionation of small particles from solutions saturated with gas
|
GB9413202D0
(en)
*
|
1994-06-30 |
1994-08-24 |
Univ Bradford |
Method and apparatus for the formation of particles
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
EP0855906B1
(en)
*
|
1995-10-17 |
2008-02-20 |
Jagotec AG |
Insoluble drug delivery
|
US5874029A
(en)
*
|
1996-10-09 |
1999-02-23 |
The University Of Kansas |
Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent
|
US5833891A
(en)
*
|
1996-10-09 |
1998-11-10 |
The University Of Kansas |
Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
|
FR2753639B1
(en)
|
1996-09-25 |
1998-12-11 |
|
PROCESS FOR THE PREPARATION OF MICROCAPSULES OF ACTIVE MATERIALS COATED WITH A POLYMER AND NOVEL MICROCAPSULES OBTAINED IN PARTICULAR BY THE PROCESS
|
US5766637A
(en)
*
|
1996-10-08 |
1998-06-16 |
University Of Delaware |
Microencapsulation process using supercritical fluids
|
DE19711393C1
(en)
*
|
1997-03-19 |
1998-08-13 |
Fraunhofer Ges Forschung |
Process for microencapsulating particles
|
US6541606B2
(en)
*
|
1997-12-31 |
2003-04-01 |
Altus Biologics Inc. |
Stabilized protein crystals formulations containing them and methods of making them
|
GB9806462D0
(en)
*
|
1998-03-26 |
1998-05-27 |
Glaxo Group Ltd |
Improved compositions for inhalation
|
GB9810559D0
(en)
*
|
1998-05-15 |
1998-07-15 |
Bradford Particle Design Ltd |
Method and apparatus for particle formation
|
GB9814172D0
(en)
*
|
1998-06-30 |
1998-08-26 |
Andaris Ltd |
Formulation for inhalation
|
US6451349B1
(en)
|
1998-08-19 |
2002-09-17 |
Quadrant Healthcare (Uk) Limited |
Spray-drying process for the preparation of microparticles
|
US6051694A
(en)
*
|
1998-09-17 |
2000-04-18 |
Castor; Trevor Percival |
Method for size reduction of proteins
|
SE9804001D0
(en)
†
|
1998-11-23 |
1998-11-23 |
Astra Ab |
New process
|
EP1185248B1
(en)
|
1999-06-09 |
2012-05-02 |
Robert E. Sievers |
Supercritical fluid-assisted nebulization and bubble drying
|
DK2280020T3
(en)
*
|
1999-06-29 |
2016-05-02 |
Mannkind Corp |
Pharmaceutical formulations comprising a peptide complexed with a diketopiperazine
|
US9006175B2
(en)
*
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
GB9915975D0
(en)
*
|
1999-07-07 |
1999-09-08 |
Bradford Particle Design Ltd |
Method for the formation of particles
|
US6680284B1
(en)
|
1999-07-13 |
2004-01-20 |
Degussa Ag |
Method for producing powdery particle-reduced formulations with the aid of compressed gases
|
FR2802445B1
(en)
*
|
1999-12-15 |
2002-02-15 |
Separex Sa |
METHOD AND DEVICE FOR CAPTURING FINE PARTICLES BY TRAPPING WITHIN A SOLID MIXTURE OF THE CARBON SNOW TYPE
|
FR2803538B1
(en)
*
|
1999-12-15 |
2002-06-07 |
Separex Sa |
METHOD AND DEVICE FOR CAPTURING FINE PARTICLES BY PERCOLATION IN A BED OF GRANULES
|
AU2729101A
(en)
*
|
1999-12-21 |
2001-07-03 |
Rxkinetix, Inc. |
Particulate drug-containing products and method of manufacture
|
US6761909B1
(en)
*
|
1999-12-21 |
2004-07-13 |
Rxkinetix, Inc. |
Particulate insulin-containing products and method of manufacture
|
CH694686A5
(en)
*
|
2000-03-04 |
2005-06-15 |
Eco2 Sa |
Product micronization of pharmaceutical substances.
|
US6620351B2
(en)
|
2000-05-24 |
2003-09-16 |
Auburn University |
Method of forming nanoparticles and microparticles of controllable size using supercritical fluids with enhanced mass transfer
|
US6821413B1
(en)
*
|
2000-08-31 |
2004-11-23 |
Fluidphase Technologies, Inc. |
Method and apparatus for continuous separation and reaction using supercritical fluid
|
US6562952B1
(en)
*
|
2000-10-31 |
2003-05-13 |
The University Of Kansas |
Precipitation of proteins from organic solutions
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
AUPR197000A0
(en)
*
|
2000-12-08 |
2001-01-11 |
Unisearch Limited |
Synthesis of small particles
|
US6977085B2
(en)
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US6869617B2
(en)
|
2000-12-22 |
2005-03-22 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
EP1354581A4
(en)
*
|
2000-12-26 |
2007-07-04 |
Takeda Pharmaceutical |
Porous substance and process for producing the same
|
IL156618A0
(en)
*
|
2000-12-28 |
2004-01-04 |
Altus Biologics Inc |
Crystals of whole antibodies and fragments thereof, methods for the preparation thereof and diagnostic kits utilizing the same
|
US7708915B2
(en)
*
|
2004-05-06 |
2010-05-04 |
Castor Trevor P |
Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
|
BR0207570B1
(en)
*
|
2001-02-26 |
2013-02-05 |
|
apparatus for forming micronized and submicronised particles of a substance, nozzle, and process performed using the apparatus.
|
US6596206B2
(en)
|
2001-03-30 |
2003-07-22 |
Picoliter Inc. |
Generation of pharmaceutical agent particles using focused acoustic energy
|
US6610223B2
(en)
|
2001-03-30 |
2003-08-26 |
Picoliter Inc. |
Focused acoustic energy in the generation of solid particles
|
US6869551B2
(en)
|
2001-03-30 |
2005-03-22 |
Picoliter Inc. |
Precipitation of solid particles from droplets formed using focused acoustic energy
|
CA2451185A1
(en)
|
2001-06-21 |
2003-01-03 |
Altus Biologics, Inc. |
Spherical protein particles and methods of making and using them
|
GB0117696D0
(en)
*
|
2001-07-20 |
2001-09-12 |
Bradford Particle Design Plc |
Particle information
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
US20080026068A1
(en)
*
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
BR0212833A
(en)
*
|
2001-09-26 |
2004-10-13 |
Baxter Int |
Preparation of submicron sized nanoparticles by dispersion and solvent or liquid phase removal
|
NZ532759A
(en)
*
|
2001-10-10 |
2005-10-28 |
Boehringer Ingelheim Pharma |
Powder processing with pressurized gaseous fluids
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
ES2372032T3
(en)
*
|
2001-10-22 |
2012-01-13 |
Dompé S.p.A. |
PROCESSING OF SUPERCRITICAL FLUIDS: PREPARATION OF PROTEIN MICROPARTICLES AND ITS STABILIZATION.
|
EP1461020A4
(en)
*
|
2001-12-07 |
2008-10-29 |
Map Pharmaceuticals Inc |
Synthesis of small particles
|
JP4681231B2
(en)
|
2002-03-20 |
2011-05-11 |
マンカインド コーポレイション |
Inhaler
|
CA2484052C
(en)
*
|
2002-04-11 |
2011-06-14 |
Medimmune Vaccines, Inc. |
Preservation of bioactive materials by spray drying
|
US7582284B2
(en)
*
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
AU2004237131B2
(en)
*
|
2003-05-08 |
2009-09-10 |
Nektar Therapeutics |
Particulate materials
|
US7767118B2
(en)
|
2003-06-03 |
2010-08-03 |
Ferro Corporation |
Nanoparticles from supercritical fluid antisolvent process using particle growth and agglomeration retardants
|
CA2532837A1
(en)
*
|
2003-07-18 |
2005-04-21 |
Baxter International, Inc. |
Method for preparing small spherical particles by controlled phase separation
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
US20050048127A1
(en)
*
|
2003-07-22 |
2005-03-03 |
Larry Brown |
Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
|
JP2007505136A
(en)
*
|
2003-09-10 |
2007-03-08 |
マツプ・フアーマシユーテイカルズ・インコーポレーテツド |
Aerosol formulation for delivering dihydroergotamine to systemic circulation by pulmonary inhalation
|
WO2005042219A1
(en)
*
|
2003-10-24 |
2005-05-12 |
Ferro Corporation |
Method of forming particles
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
US20050153874A1
(en)
*
|
2004-01-12 |
2005-07-14 |
Mannkind Corporation |
Method of reducing serum proinsulin levels in type 2 diabetics
|
EP1711163A2
(en)
*
|
2004-02-05 |
2006-10-18 |
Baxter International Inc. |
Dispersions prepared by use of self-stabilizing agents
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
PT2319500E
(en)
*
|
2004-03-12 |
2013-01-23 |
Biodel Inc |
Rapid acting drug delivery compositions
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
US8728525B2
(en)
*
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
ATE409025T1
(en)
|
2004-05-12 |
2008-10-15 |
Baxter Int |
NUCLEIC ACID MICROBEDS, THEIR PRODUCTION AND DELIVERY
|
MXPA06012989A
(en)
*
|
2004-05-12 |
2007-06-12 |
Baxter Int |
Delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes.
|
CA2566075A1
(en)
|
2004-05-12 |
2005-12-01 |
Baxter Healthcare S.A. |
Microspheres comprising protein and showing injectability at high concentrations of said agent
|
BRPI0514263B8
(en)
|
2004-08-20 |
2021-05-25 |
Mannkind Corp |
method for the synthesis of n-protected bis-3,6-[4-aminobutyl]-2,5-diketopiperazine n-protected
|
KR101306384B1
(en)
|
2004-08-23 |
2013-09-09 |
맨카인드 코포레이션 |
Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
|
EP1885335A1
(en)
*
|
2005-04-27 |
2008-02-13 |
BAXTER INTERNATIONAL INC. (a Delaware corporation) |
Surface-modified microparticles and methods of forming and using the same
|
ES2285605T3
(en)
*
|
2005-06-11 |
2007-11-16 |
Tutech Innovation Gmbh |
PROCEDURE FOR THE MICROENCAPSULATION OF ORGANIC SUBSTANCES IN THE FORM OF A PARTICLE BY SPRAYING A GAS HYPERCRITICAL SUPPORT INERT TOGETHER WITH COATING MATERIAL FOR ORGANIC SUBSTANCES IN A FLUIDIZED HIGH PRESSURE MILK IN AN AUTOCLAVE.
|
AU2006259594A1
(en)
*
|
2005-06-14 |
2006-12-28 |
Baxter Healthcare S.A. |
Pharmaceutical formulations for minimizing drug-drug interactions
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
EP1928423B1
(en)
|
2005-09-14 |
2015-12-09 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
EP1954245A2
(en)
*
|
2005-11-15 |
2008-08-13 |
Baxter International Inc. |
Compositions of lipoxygenase inhibitors
|
KR101787939B1
(en)
*
|
2006-01-24 |
2017-10-18 |
안선 바이오파르마, 아이엔씨. |
Technology for preparation of macromolecular microspheres
|
WO2007098500A2
(en)
|
2006-02-22 |
2007-08-30 |
Mannkind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
CA2649109A1
(en)
*
|
2006-04-12 |
2007-10-25 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
DE102006020148A1
(en)
*
|
2006-05-02 |
2007-11-08 |
Universität Bremen |
Genetically engineered perlucin and its use for the production of biomaterials
|
US20070281031A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Guohan Yang |
Microparticles and methods for production thereof
|
EP2647712A3
(en)
*
|
2006-08-04 |
2013-11-20 |
Baxter International Inc |
Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
|
AU2007319577A1
(en)
*
|
2006-10-06 |
2008-05-22 |
Baxter Healthcare S.A. |
Microencapsules containing surface-modified microparticles and methods of forming and using the same
|
US20090152176A1
(en)
*
|
2006-12-23 |
2009-06-18 |
Baxter International Inc. |
Magnetic separation of fine particles from compositions
|
CN104188907A
(en)
*
|
2007-02-11 |
2014-12-10 |
Map药物公司 |
Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
|
US8426467B2
(en)
*
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US20080293814A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Deepak Tiwari |
Concentrate esmolol
|
US8722736B2
(en)
*
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8785396B2
(en)
|
2007-10-24 |
2014-07-22 |
Mannkind Corporation |
Method and composition for treating migraines
|
MX2010007342A
(en)
*
|
2008-01-04 |
2010-08-26 |
Biodel Inc |
Insulin formulations for insulin release as a function of tissue glucose levels.
|
CA2982550C
(en)
|
2008-06-13 |
2020-08-25 |
Mannkind Corporation |
A dry powder inhaler and system for drug delivery
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
CN102065942B
(en)
|
2008-06-20 |
2013-12-11 |
曼金德公司 |
An interactive apparatus and method for real-time profiling of inhalation efforts
|
TWI494123B
(en)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
Use of ultrarapid acting insulin
|
US20100047292A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Baxter International Inc. |
Methods of processing microparticles and compositions produced thereby
|
US8323615B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
US8323685B2
(en)
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US8367427B2
(en)
*
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
WO2010065387A1
(en)
*
|
2008-12-01 |
2010-06-10 |
Innovative Technologies, Inc. |
Improved preparation of organic compounds for enhanced reactivity
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
PL2405963T3
(en)
|
2009-03-11 |
2014-04-30 |
Mannkind Corp |
Apparatus, system and method for measuring resistance of an inhaler
|
ES2943333T3
(en)
|
2009-06-12 |
2023-06-12 |
Mannkind Corp |
Diketopiperazine microparticles with defined surface areas
|
EP2496295A1
(en)
|
2009-11-03 |
2012-09-12 |
MannKind Corporation |
An apparatus and method for simulating inhalation efforts
|
AU2011271097B2
(en)
|
2010-06-21 |
2014-11-27 |
Mannkind Corporation |
Dry powder drug delivery system and methods
|
US9138705B2
(en)
|
2010-11-22 |
2015-09-22 |
Hong Kong Polytechnic University |
Method for precipitating a solute from a solution
|
MX350838B
(en)
|
2011-02-11 |
2017-09-18 |
Grain Proc Corporation * |
Salt composition.
|
CN103826988B
(en)
|
2011-04-01 |
2016-03-09 |
曼金德公司 |
For the blister package of pharmaceutical kit
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
JP6018640B2
(en)
|
2011-10-24 |
2016-11-02 |
マンカインド コーポレイション |
Analgesic composition effective for alleviating pain, and dry powder and dry powder drug delivery system comprising the composition
|
JP6267649B2
(en)
|
2011-11-18 |
2018-01-24 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Polymer protein fine particles
|
JP2015527310A
(en)
|
2012-06-28 |
2015-09-17 |
アンサン バイオファーマ, インコーポレイテッドAnsun Biopharma, Inc. |
Particulate preparation for delivery to lower and central respiratory tract and production method
|
US9802012B2
(en)
|
2012-07-12 |
2017-10-31 |
Mannkind Corporation |
Dry powder drug delivery system and methods
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
KR102391750B1
(en)
|
2013-03-15 |
2022-04-28 |
맨카인드 코포레이션 |
Microcrystalline diketopiperazine compositions and methods
|
CN105451716A
(en)
|
2013-07-18 |
2016-03-30 |
曼金德公司 |
Heat-stable dry powder pharmaceutical compositions and methods
|
US11446127B2
(en)
|
2013-08-05 |
2022-09-20 |
Mannkind Corporation |
Insufflation apparatus and methods
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
GB201409451D0
(en)
|
2014-05-28 |
2014-07-09 |
Ipabc Ltd |
Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
CN108310797A
(en)
*
|
2018-04-09 |
2018-07-24 |
南通市华安超临界萃取有限公司 |
A kind of supercritical fluid recrystallization device
|
MX2022006236A
(en)
|
2019-11-25 |
2022-06-22 |
Regeneron Pharma |
Sustained release formulations using non-aqueous emulsions.
|
EP4251128A1
(en)
|
2020-11-25 |
2023-10-04 |
Regeneron Pharmaceuticals, Inc. |
Sustained release formulations using non-aqueous membrane emulsification
|
EP4262757A1
(en)
|
2020-12-17 |
2023-10-25 |
Regeneron Pharmaceuticals, Inc. |
Fabrication of protein-encapsulating microgels
|